Woodline Partners’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Hold |
95,120
| – | – | 0.01% | 797 |
|
|
2025
Q1 | $633K | Buy |
95,120
+217
| +0.2% | +$1.44K | ﹤0.01% | 810 |
|
|
2024
Q4 | $1.05M | Buy |
94,903
+521
| +0.6% | +$5.75K | 0.01% | 750 |
|
|
2024
Q3 | $1.16M | Sell |
94,382
-5,800
| -6% | -$71.3K | 0.01% | 499 |
|
|
2024
Q2 | $1.35M | Sell |
100,182
-6,722
| -6% | -$90.8K | 0.01% | 441 |
|
|
2024
Q1 | $1.44M | Buy |
106,904
+50,000
| +88% | +$675K | 0.01% | 442 |
|
|
2023
Q4 | $299K | Hold |
56,904
| – | – | ﹤0.01% | 442 |
|
|
2023
Q3 | $224K | Sell |
56,904
-40,120
| -41% | -$158K | ﹤0.01% | 548 |
|
|
2023
Q2 | $1.03M | Hold |
97,024
| – | – | 0.01% | 481 |
|
|
2023
Q1 | $808K | Buy |
+97,024
| New | +$808K | 0.01% | 488 |
|